Back

Inclisiran patient experiences survey

13 June 2025 (14:55 - 15:40)
Organised by: Logo
Congress Presentation Part of: Pre-existing conditions, treatment strategies, and procedural outcomes Allied Professions in Cardiovascular Care ACNAP Premium Access ACNAP Congress 2025 Association of Cardiovascular Nursing and Allied Professions (ACNAP)

About the speaker

Photo
Mrs Abigail Barrowcliff

Leeds Teaching Hospitals, Leeds (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Effect of valsalva maneuver training before the transesophageal echocardiography
Mrs K. Kim (Yangsan, KR)
Abstract Slides
Presentation thumbnail
What is the treatment and management for patients with hypokalaemia? A critical review of the literature
Mr F. Pavlou (Belfast, GB)
Abstract Slides
Presentation thumbnail
Vascular access complications after interventional and structural procedures: Prospective observational cohort study to guide contemporary nursing practice
Ms J. Polderman (Vancouver, CA)
Abstract Slides
Presentation thumbnail
Pre-existing cardiovascular disease in the critically ill and its impact on hospital readmission: a retrospective observational cohort study
Miss N. Rea (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Comparative risk of permanent pacemaker implantation in SAVR with sutureless valve prosthesis versus TAVI
Mrs E. Sigala (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Pre-existing conditions, treatment strategies, and procedural outcomes

The Event

Event poster

ACNAP Congress 2025

13 June 2025 14:55 CET
You may be interested in
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients
thumbnail
Congress Presentation
First clinical experiences with inclisiran in real world setting
thumbnail
Congress Presentation
Efficacy and safety of inclisiran monotherapy in patients with hypercholesterolemia without background lipid-lowering therapy: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources